Ethyl 4-(2-(piperidin-3-yl)ethoxy)benzoate hydrochloride

Catalog No.: 
ACSAUB869
CAS No.: 
1220029-84-4
Molecular Formula: 
C16H24ClNO3
Molecular Weight: 
313.83
Ethyl 4-(2-(piperidin-3-yl)ethoxy)benzoate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$163.00InquiryInquiry
5g95%$491.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 4-(2-(piperidin-3-yl)ethoxy)benzoate hydrochloride
IUPAC Nameethyl 4-(2-(piperidin-3-yl)ethoxy)benzoate hydrochloride
Molecular FormulaC16H24ClNO3
Molecular Weight313.83
SMILESO=C(OCC)C1=CC=C(OCCC2CNCCC2)C=C1.[H]Cl
InChI KeyKATWAKFCWJLPRM-UHFFFAOYSA-N
SynonymETHYL 4-(2-(PIPERIDIN-3-YL)ETHOXY)BENZOATE HYDROCHLORIDE;Ethyl 4-[2-(3-piperidinyl)ethoxy]benzoatehydrochloride
CAS No.1220029-84-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSAUB869 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUVRZ748 route compound structure diagram
    ACUVRZ74835285-68-8In Stock
  2. Plus
  3. ACUNST851 route compound structure diagram
    ACUNST85116780-04-4In Stock
  4. Then
  5. ACSAUB869 route product structure diagram
    ACSAUB8691220029-84-4
Inquiry

2. ACSAUB869 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSAUB869 route product structure diagram
    ACSAUB8691220029-84-4
Inquiry

3. ACSAUB869 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSAUB869 route product structure diagram
    ACSAUB8691220029-84-4
Inquiry

Comments (0)